EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, Anticancer Evaluation and Molecular Modeling Studies of New Thiazolidinone‐Benzoate Scaffold as EGFR Inhibitors, Cell Cycle Interruption and Apoptosis Inducers in HepG2

Salwa Magdy Eldaly iD, Dalia Salama Zakaria, Nadia Hanafy Metwally iD

Chemistry & Biodiversity · 2023

DOI: 10.1002/cbdv.202300138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Salwa Magdy Eldaly und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Cairo University, 12613, Giza, Egypt. Hauptthemen laut MEDLINE: Apoptosis, Antineoplastic Agents, Protein Kinase Inhibitors, Drug Design. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 84 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthesis of new anticancer candidates with protein kinases inhibitory potency is a major goal of pharmaceutical science and synthetic research. This current work represents the synthesis of a series of substituted benzoate‐thiazolidinones. Most prepared thiazolidinones were evaluated in vitro for their potential anticancer activity against three cell lines by MTT assay, and they found to be more effective against cancer cell lines with no harm toward normal cells. Thiazolidinones 5 c and 5 h were further evaluated to be kinase inhibitors against EGFR showing effective inhibitory impact (with IC 50 value; 0.2±0.009 and 0.098±0.004 μM, for 5 c and 5 h , respectively). Furthermore, 5 c and 5 h have effects on cell cycle and apoptosis induction capability in HepG2 cell lines by DNA‐flow cytometry analysis and annexin V‐FITC apoptosis assay, respectively. The results showed that they have effect of disrupting the cell cycle and causing cell mortality by apoptosis in the treated cells. Moreover, molecular docking studies showed better binding patterns for 5 c and 5 h with the active site of the epidermal growth factor receptor (EGFR) protein kinase (PDB code 1M17). Finally, toxicity risk and physicochemical characterization by Osiris method was performed on most of the compounds, revealing excellent properties as possible drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisAntineoplastic AgentsProtein Kinase InhibitorsDrug DesignThiazolidinesBenzoatesHumansErbB ReceptorsDrug Screening Assays, AntitumorHep G2 CellsStructure-Activity RelationshipMolecular Docking SimulationCell ProliferationCell CycleMolecular StructureDose-Response Relationship, DrugModels, Molecular

Stichwörter der Autor:innen

EGFR protein kinaseMTT assayannexin V-FITCcell cycle DNA-flow cytometricthiazolidinones

Substanzen

ErbB ReceptorsAntineoplastic AgentsProtein Kinase InhibitorsThiazolidinesEGFR protein, humanBenzoates

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Cairo University, 12613, Giza, Egypt.

ORCID-Profile: Salwa Magdy Eldaly, Nadia Hanafy Metwally

Zitieren

APA

Magdy Eldaly, S., Salama Zakaria, D., & Hanafy Metwally, N. (2023). Design, Synthesis, Anticancer Evaluation and Molecular Modeling Studies of New Thiazolidinone‐Benzoate Scaffold as EGFR Inhibitors, Cell Cycle Interruption and Apoptosis Inducers in HepG2. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202300138

Vancouver

Magdy Eldaly S, Salama Zakaria D, Hanafy Metwally N. Design, Synthesis, Anticancer Evaluation and Molecular Modeling Studies of New Thiazolidinone‐Benzoate Scaffold as EGFR Inhibitors, Cell Cycle Interruption and Apoptosis Inducers in HepG2. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202300138

BibTeX
@article{MagdyEldaly2023,
  author = {Magdy Eldaly, Salwa and Salama Zakaria, Dalia and Hanafy Metwally, Nadia},
  title = {Design, Synthesis, Anticancer Evaluation and Molecular Modeling Studies of New Thiazolidinone‐Benzoate Scaffold as EGFR Inhibitors, Cell Cycle Interruption and Apoptosis Inducers in HepG2},
  journal = {Chemistry & Biodiversity},
  year = {2023},
  doi = {10.1002/cbdv.202300138}
}
Kostenlos starten →